Generative Data Intelligence

Tag: Microdose

Wellbeing Subsidiary KGK Science Receives Approval for First-of-its-Kind Psylocibin Clinical Trial

KGK has received approval from Health Canada for Phase II clinical trial to test the efficacy of psilocybin on Fragile X syndrome VANCOUVER, British Columbia–(BUSINESS...

Top News

No posts to display

Latest Intelligence

spot_img
spot_img
spot_img